These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial. Willemsen LM, Janssen PWA, Hackeng CM, Kelder JC, Tijssen JGP, van Straten AHM, Soliman-Hamad MA, Deneer VHM, Daeter EJ, Sonker U, Klein P, Ten Berg JM. Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246 [Abstract] [Full Text] [Related]
11. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting. Gao C, Ren C, Li D, Li L. Ann Thorac Surg; 2009 Jul; 88(1):59-62. PubMed ID: 19559191 [Abstract] [Full Text] [Related]
15. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study. van der Meer J, Brutel de la Rivière A, van Gilst WH, Hillege HL, Pfisterer M, Kootstra GJ, Dunselman PH, Mulder BJ, Lie KI. J Am Coll Cardiol; 1994 Nov 01; 24(5):1181-8. PubMed ID: 7930237 [Abstract] [Full Text] [Related]